Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1869451 | 1.00 | CA1 (0.48) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL5139785 | 0.93 | CA12 (0.43) | CA1CA12CA2CA9CYP19A1 | |
| Propionic Acid SCHEMBL15378064 | 0.89 | FFAR3 (0.42) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL17169727 | 0.86 | TDP1 (0.44) | CA1CA12CA2CA9CYP19A1 | |
| Ethyl Acetate SCHEMBL31147805 | 0.85 | ALDH1A1 (0.54) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL4675873 | 0.85 | BLM (0.39) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL11063918 | 0.84 | CA1 (0.36) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL7222773 | 0.83 | RARB (0.41) | CA1CA12CA2CA9ALDH1A1 | |
| Ethylene Glycol Diisobutanoate SCHEMBL843146 | 0.83 | TSHR (0.36) | ALDH1A1CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL14462537 | 0.83 | BLM (0.52) | CA1CA12CA2CA9CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4721579-A1 | BEER-FLAVOURED NON-ALCOHOLIC BEVERAGES AND METHODS OF MAKING | MFG Capital GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4610284-A1 | MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT | Mitsubishi Chemical Corporation (JP) | 2025-09-03 | — | — | EP | claimed |
| EP-4606226-A2 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-20250250376-A1 | MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | claimed |
| EP-4578292-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| CN-120092027-A | Monomer composition, methacrylic resin composition, method for producing same, and resin molded article | 三菱化学株式会社 | 2025-06-03 | — | — | CN | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| WO-2006092033-A2 | PROCESS FOR THE ISOLATION OF POLYHYDROXYALKANOATES (PHAS) FROM A CELL MASS BY SOLVENT EXTRACTION INVOLVING A STEP OF TREATING THE PHA SOLUTION WITH WATER AND/OR STEAM FOR EVAPORATION OF THE PHA SOLVENT AND PRECIPITATION OF THE PHA | PHB INDUSTRIAL S.A. (BR) | 2006-09-08 | — | — | WO | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20020002933-A1 | Environmentally preferred fluids and fluid blends | YEZRIELEV ALBERT ILYA (US) | 2002-01-10 | — | — | US | claimed |
| US-6280519-B1 | Environmentally preferred fluids and fluid blends | EXXON CHEMICAL PATENTS INC. | 2001-08-28 | — | — | US | claimed |
| US-4442019-A | NON-COAGULATING CONDUCTIVE PARTICLES IN DIELECTRIC FLUID | MARKS ALVIN M | 1984-04-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | CA1 151/4885CA12 406/4885CA2 540/4885 |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | CA1 2172/4885CA12 2980/4885CA2 3862/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | CA1 1581/4885CA12 2608/4885CA2 3440/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | CA1 1069/4885CA12 1152/4885CA2 1526/4885 |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | CA1 4083/4885CA12 2286/4885CA2 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.